I've been thinking about this most of the day today. Since the FDA/CDC/WHO has really lowered the bar in acceptable vaccine efficacy, why couldn't there be room in the market space for Leronlimab AND a vaccine? This may have been mentioned here before but it finally soaked into my thick noggin.
Even if a vaccine were found to be 50% effective, what do we do with the remaining 50%, or more, of the population that are susceptible to contracting COVID-19? Do we just let them take Remdesivir and live with not only the secondary morbidity effects of COVID-19 PLUS the potential side-effects of Remdesivir....but heck...they get out of the hospital 4 days earlier so they can go home and in time become even greater liabilities to the healthcare system?
I don't want to strip these poor people of their humanity with such a callous statement but how as a society are we going to deal with this more and more evident issue of lasting effects of COVID-19?
The investigation and treatment of these secondary COVID-19 morbidity effects NEEDS to be addressed NOW because it will take MONTHS to arrive at a DECISION which then needs to be executed into ACTION.
This translate into TIME. TIME that many of our loves ones do not have.
I believe NP, Dr Kelly, and Dr. BP have all mentioned that this is a growing concern and requires action.
Here are some links concerning the after effects of COVID-19 that are becoming more and more evident:
If you're pressed for time, interest, or patience just watch these videos: